{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:57:20Z","timestamp":1770713840637,"version":"3.49.0"},"reference-count":12,"publisher":"Becaris Publishing Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>In this latest update we highlight a report from the European Medicines Agency on their use of real-world evidence (RWE) in decision making, RWE reporting guidance from the Canadian Agency for Drugs and Technologies in Health and highlight some new data demonstrating the value medicines for spinal muscular atrophy have brought patients.<\/jats:p>","DOI":"10.57264\/cer-2023-0141","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:42:03Z","timestamp":1694781723000},"source":"Crossref","is-referenced-by-count":2,"title":["R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13"],"prefix":"10.57264","volume":"12","author":[{"given":"Benjamin D","family":"Bray","sequence":"first","affiliation":[{"name":"Lane Clark &amp; Peacock, London, W1U 1DQ, UK"},{"name":"Department of Population Health Sciences, King's College London, SE1 1UL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreeram V","family":"Ramagopalan","sequence":"additional","affiliation":[{"name":"Lane Clark &amp; Peacock, London, W1U 1DQ, UK"},{"name":"Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"key":"e_1_3_5_2_2","unstructured":"European Medicines Agency. Use of real-world evidence in regulatory decision making \u2013 EMA publishes review its studies. https:\/\/www.ema.europa.eu\/en\/news\/use-real-world-evidence-regulatory-decision-making-ema-publishes-review-its-studies (2023)."},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10654-018-0389-5","article-title":"Performing studies using the UK Clinical Practice Research Datalink: to link or not to link?","volume":"33","author":"McDonald L","year":"2018","unstructured":"McDonald L, Schultze A, Carroll R, Ramagopalan SV. Performing studies using the UK Clinical Practice Research Datalink: to link or not to link? Eur. J. Epidemiol. 33, 601\u2013605 (2018).","journal-title":"Eur. J. Epidemiol."},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"E1293","DOI":"10.1503\/cmaj.733383","article-title":"Real-world data really matter","volume":"189","author":"McDonald L","year":"2017","unstructured":"McDonald L, Ramagopalan SV, Lees M. Real-world data really matter. CMAJ. 189, E1293 (2017).","journal-title":"CMAJ."},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"j4866","DOI":"10.1136\/bmj.j4866","article-title":"Lack of data sharing in observational studies","volume":"359","author":"McDonald L","year":"2017","unstructured":"McDonald L, Schultze A, Simpson A, Graham S, Wasiak R, Ramagopalan SV. Lack of data sharing in observational studies. BMJ. 359, j4866 (2017).","journal-title":"BMJ."},{"key":"e_1_3_5_6_2","unstructured":"NICE real-world evidence framework. https:\/\/www.nice.org.uk\/corporate\/ecd9\/chapter\/overview (2022)."},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jval.2022.01.014","article-title":"The (harsh) reality of real-world data external comparators for health technology assessment","volume":"25","author":"Cox O","year":"2022","unstructured":"Cox O, Sammon C, Simpson A, Wasiak R, Ramagopalan S, Thorlund K. The (harsh) reality of real-world data external comparators for health technology assessment. Value Health. 25, 1253\u20131256 (2022).","journal-title":"Value Health."},{"key":"e_1_3_5_8_2","unstructured":"CADTH. Guidance for Reporting Real-World Evidence. https:\/\/www.cadth.ca\/guidance-reporting-real-world-evidence"},{"key":"e_1_3_5_9_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pds.5507","article-title":"HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: a good practices report of a joint ISPE\/ISPOR task force","volume":"32","author":"Wang SV","year":"2023","unstructured":"Wang SV, Potteg\u00e5rd A, Crown W HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: a good practices report of a joint ISPE\/ISPOR task force. Pharmacoepidemiol. Drug Saf. 32, 44\u201355 (2023).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0008"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2022-0029"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0092"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0120"}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2023-0141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:10:45Z","timestamp":1698747045000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2023-0141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.57264\/cer-2023-0141"],"URL":"https:\/\/doi.org\/10.57264\/cer-2023-0141","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]},"article-number":"e230141"}}